Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade, Inc. - common stock (NQ: ACCD )

6.835 +0.005 (+0.07%)
Streaming Delayed Price Updated: 3:37 PM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,939,984
Open 6.830
Bid (Size) 6.830 (260)
Ask (Size) 6.840 (301)
Prev. Close 6.830
Today's Range 6.820 - 6.900
52wk Range 3.080 - 13.93
Shares Outstanding 76,232,192
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Paycor HCM, Inc. (Nasdaq - PYCR), Accolade, Inc. (Nasdaq - ACCD)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire

Performance

YTD
+99.85%
+99.85%
1 Month
+95.85%
+95.85%
3 Month
+86.24%
+86.24%
6 Month
+99.85%
+99.85%
1 Year
-48.34%
-48.34%

More News

Read More
Accolade Q3 Earnings Assessment
Via Benzinga
Earnings Scheduled For January 9, 2025
Via Benzinga
What's Going On With Accolade Stock Wednesday?
Via Benzinga
Breaking Down Accolade: 8 Analysts Share Their Views
Via Benzinga
ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD
From Kahn Swick & Foti, LLC
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Is Accolade Stock Trading Over 100% On Tuesday?
Via Benzinga
Shareholder Alert: Ademi LLP Investigates Whether Accolade, Inc. Is Obtaining a Fair Price for Its Public Shareholders
From Ademi LLP
Via Business Wire
Forecasting The Future: 6 Analyst Projections For Accolade
Via Benzinga
Uncovering Potential: Accolade's Earnings Preview
Via Benzinga
Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings
Via Benzinga
ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Transcarent To Acquire Accolade
From Transcarent
Via Business Wire
Transcarent To Acquire Accolade
From Accolade, Inc.
Via GlobeNewswire
Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms
Via Benzinga
Accolade Announces Results for Fiscal Second Quarter 2025
From Accolade, Inc.
Via GlobeNewswire
Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In 'Greed' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
PepsiCo, MEDIROM Healthcare Technologies And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Apple To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.